Cargando…

Evolution of the Human Cytokine Response from Acute Illness to Disease Resolution in SARS-Cov-2 Infection—Implications for Therapeutic Monitoring and Therapeutic Targets

Detalles Bibliográficos
Autores principales:	Drewett, George P., Copaescu, Ana, Mouhtouris, Effie, Hannan, Natalie, James, Fiona, Smibert, Olivia, Holmes, Natasha E., Trubiano, Jason A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2021
Materias:	Letter to Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8051826/ https://www.ncbi.nlm.nih.gov/pubmed/33864183 http://dx.doi.org/10.1007/s10875-021-01039-x

Ejemplares similares

The Role of Immunological and Clinical Biomarkers to Predict Clinical COVID-19 Severity and Response to Therapy—A Prospective Longitudinal Study
por: Copaescu, Ana, et al.
Publicado: (2021)

The use of procalcitonin as an antimicrobial stewardship tool and a predictor of disease severity in coronavirus disease 2019 (COVID-19)
por: Drewett, George P., et al.
Publicado: (2021)

The role of IL-6 and other mediators in the cytokine storm associated with SARS-CoV-2 infection
por: Copaescu, Ana, et al.
Publicado: (2020)

Corrigendum: Dose Dependent Antimicrobial Cellular Cytotoxicity—Implications for ex vivo Diagnostics
por: Copaescu, Ana, et al.
Publicado: (2021)

Dose Dependent Antimicrobial Cellular Cytotoxicity—Implications for ex vivo Diagnostics
por: Copaescu, Ana, et al.
Publicado: (2021)

Asystolic cardiac arrest following liposomal amphotericin B infusion: anaphylaxis or compliment activation-related pseudoallergy?
por: Drewett, George P., et al.
Publicado: (2021)

Blister fluid as a cellular input for ex vivo diagnostics in drug-induced severe cutaneous adverse reactions improves sensitivity and explores immunopathogenesis
por: Awad, Andrew, et al.
Publicado: (2021)

Defective Severe Acute Respiratory Syndrome Coronavirus 2 Immune Responses in an Immunocompromised Individual With Prolonged Viral Replication
por: Gordon, Claire L, et al.
Publicado: (2021)

COVID-Care – a safe and successful digital self-assessment tool for outpatients with proven and suspected coronavirus-2019
por: Drewett, George P, et al.
Publicado: (2021)

Immune responses in COVID-19 respiratory tract and blood reveal mechanisms of disease severity
por: Zhang, Wuji, et al.
Publicado: (2021)

1578. Back to Bactrim–Utilizing Preferred Prophylaxis Strategies in Immunocompromised Hosts Via a Trimethoprim-Sulfamethoxazole Rechallenge Program
por: Smibert, Olivia, et al.
Publicado: (2018)

Use of a penicillin allergy clinical decision rule to enable direct oral penicillin provocation: an international multicentre randomised control trial in an adult population (PALACE): study protocol
por: Copaescu, Ana-Maria, et al.
Publicado: (2022)

The Safety and Efficacy of an Oral Penicillin Challenge Program in Cancer Patients: A Multicenter Pilot Study
por: Trubiano, Jason A, et al.
Publicado: (2018)

Tools to improve the diagnosis and management of T-cell mediated adverse drug reactions
por: Copaescu, Ana Maria, et al.
Publicado: (2022)

1787. The Safety and Efficacy of an Oral Penicillin Rechallenge Program in Cancer Patients: A Pilot Multicenter Study
por: Smibert, Olivia, et al.
Publicado: (2018)

Immunosuppression for COVID-19: repurposing medicines in a pandemic
por: Shivakumar, Senthuran, et al.
Publicado: (2020)

2743. Pre-Transplant Human T-Lymphotropic Virus Screening In Allogeneic Hematopoietic Stem Cell Transplant Recipients At A Large Metropolitan Tertiary Referral Centre In Melbourne, Australia
por: Paykin, Gabriel, et al.
Publicado: (2023)

An Updated Review of the Diagnostic Methods in Delayed Drug Hypersensitivity
por: Copaescu, Ana, et al.
Publicado: (2021)

Validation of the PEN-FAST Score in a Pediatric Population
por: Copaescu, Ana Maria, et al.
Publicado: (2022)

Are NKT cells a useful predictor of COVID-19 severity?
por: Koay, Hui-Fern, et al.
Publicado: (2022)

Study protocol: Australasian Registry of Severe Cutaneous Adverse Reactions (AUS-SCAR)
por: James, Fiona, et al.
Publicado: (2022)

Therapeutic monitoring of amikacin and gentamicin in critically and noncritically ill patients
por: Kovačević, Tijana, et al.
Publicado: (2016)

Therapeutic Drug Monitoring of Isavuconazole—But What about the Critically Ill?
por: Salhotra, Ripenmeet
Publicado: (2023)

Therapeutic Drug Monitoring of Antimicrobials in Critically Ill Obese Patients
por: Gorham, Julie, et al.
Publicado: (2023)

Engineering cytokine therapeutics
por: Deckers, Jeroen, et al.
Publicado: (2023)

Oral challenge vs routine care to assess low-risk penicillin allergy in critically ill hospital patients (ORACLE): a pilot randomised controlled trial
por: Rose, Morgan, et al.
Publicado: (2023)

Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper(#)
por: Abdul-Aziz, Mohd H., et al.
Publicado: (2020)

Hematopoietic cytokines as therapeutic players in early stages Parkinson’s disease
por: Farmer, Kyle, et al.
Publicado: (2015)

Pre-Clinical Investigation of Cardioprotective Beta-Blockers as a Therapeutic Strategy for Preeclampsia
por: Binder, Natalie K., et al.
Publicado: (2021)

COVID-MATCH65—A prospectively derived clinical decision rule for severe acute respiratory syndrome coronavirus 2
por: Trubiano, Jason A., et al.
Publicado: (2020)

Precision Breast Cancer Medicine: Early Stage Triple Negative Breast Cancer—A Review of Molecular Characterisation, Therapeutic Targets and Future Trends
por: Pinilla, Karen, et al.
Publicado: (2022)

318. Beta-lactam Therapeutic Drug Monitoring Improves Attainment of Target Drug Levels in Critically Ill Patients
por: Ausman, Sara, et al.
Publicado: (2023)

Extensive Therapeutic Drug Monitoring of Colistin in Critically Ill Patients Reveals Undetected Risks
por: Ehrentraut, Stefan Felix, et al.
Publicado: (2020)

How do we use therapeutic drug monitoring to improve outcomes from severe infections in critically ill patients?
por: Wong, Gloria, et al.
Publicado: (2014)

Evolution Toward Severe Covid-19 From Biological Monitoring to Therapeutic Considerations
por: Carvelli, Julien, et al.
Publicado: (2020)

SARS-CoV-2 infection results in immune responses in the respiratory tract and peripheral blood that suggest mechanisms of disease severity
por: Zhang, Wuji, et al.
Publicado: (2022)

Does Beta-lactam Pharmacokinetic Variability in Critically Ill Patients Justify Therapeutic Drug Monitoring? A Systematic Review
por: Sime, Fekade Bruck, et al.
Publicado: (2012)

Multi-site assessment of rapid, point-of-care antigen testing for the diagnosis of SARS-CoV-2 infection in a low-prevalence setting: A validation and implementation study
por: Muhi, Stephen, et al.
Publicado: (2021)

Are we ready for therapeutic drug monitoring of biologic therapeutics?
por: Krieckaert, Charlotte LM, et al.
Publicado: (2011)

Serum Collected from Preeclamptic Pregnancies Drives Vasoconstriction of Human Omental Arteries—A Novel Ex Vivo Model of Preeclampsia for Therapeutic Development
por: Fato, Bianca R., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rbt87r8u1jsjioe229ian3b5ka